Eisai
4523.T
#2085
Rank
NZ$12.07 B
Marketcap
$42.80
Share price
-4.47%
Change (1 day)
-35.51%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): $3.54

According to Eisai's latest financial reports the company's current EPS (TTM) is $3.76. In 2022 the company made an earnings per share (EPS) of $2.76 a decrease over its 2021 EPS that were of $12.25.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$3.5428.3%
2022$2.76-77.48%
2021$12.25-41.88%
2020$21.08-0.94%
2019$21.2852.59%
2018$13.94124.17%
2017$6.22-49.42%
2016$12.3037.08%
2015$8.97-11.75%
2014$10.17-3.23%
2013$10.51-18.56%
2012$12.90-15.51%
2011$15.27-3.75%
2010$15.86-1.36%
2009$16.08